121 related articles for article (PubMed ID: 2279765)
21. Estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues in vitro.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1987 Jun; 47(11):2852-9. PubMed ID: 3105869
[TBL] [Abstract][Full Text] [Related]
22. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
[TBL] [Abstract][Full Text] [Related]
23. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
24. Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues.
Donnay I; Rauïs J; Wouters-Ballman P; Devleeschouwer N; Leclercq G; Verstegen JP
J Reprod Fertil Suppl; 1993; 47():501-12. PubMed ID: 8229969
[TBL] [Abstract][Full Text] [Related]
25. Influence of the estrous cycle during carcinogen exposure on nitrosomethylurea-induced rat mammary carcinoma.
Lindsey WF; Das Gupta TK; Beattie CW
Cancer Res; 1981 Oct; 41(10):3857-62. PubMed ID: 7197191
[TBL] [Abstract][Full Text] [Related]
26. Progestogens and mammary tumours in the beagle bitch.
Briggs MH
Res Vet Sci; 1980 Mar; 28(2):199-202. PubMed ID: 7414066
[TBL] [Abstract][Full Text] [Related]
27. Tamoxifen tolerance and steroid receptors in a tumor model.
Kellen JA; Sutherland DJ
In Vivo; 1988; 2(3-4):299-300. PubMed ID: 2979847
[TBL] [Abstract][Full Text] [Related]
28. Luteinizing hormone releasing hormone, estrogen, and progesterone receptors in canine mammary lesions and tumor cell lines.
Sartin EA; Rahe CH; Wright JC; Sartin JL
Anticancer Res; 1995; 15(5B):2029-32. PubMed ID: 8572597
[TBL] [Abstract][Full Text] [Related]
29. Effect of ovariectomy on hormone receptors and growth of N-nitrosomethylurea-induced mammary tumors in the rat.
Arafah BM; Gullino PM; Manni A; Pearson OH
Cancer Res; 1980 Dec; 40(12):4628-30. PubMed ID: 6254648
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
31. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
32. Interactions between prolactin and ovarian secretions during mammary tumorigenesis in the mouse.
Edery M; Goussard J; Vives C; Rudali G; Drosdowsky MA
Biomedicine; 1980 Dec; 33(8):265-7. PubMed ID: 7213925
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of mammary gland tumors by short-term treatment of estradiol-3-benzoate associated with down-regulation of estrogen receptor ERalpha and ERbeta.
Kang JS; Kim S; Che JH; Nam KT; Kim DJ; Jang DD; Yang KH
Oncol Rep; 2004 Oct; 12(4):689-93. PubMed ID: 15375486
[TBL] [Abstract][Full Text] [Related]
34. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
35. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
[TBL] [Abstract][Full Text] [Related]
36. Effects of medroxyprogesterone acetate on DMBA-induced mammary tumors.
Racca S; Conti G; Crispino A; Gallo E; Di Carlo F
Chemioterapia; 1985 Jun; 4(3):236-8. PubMed ID: 3928182
[TBL] [Abstract][Full Text] [Related]
37. Effects of ischemia on breast tumor steroid hormone-receptor levels.
Ellis LM; Wittliff JL; Bryant MS; Sitren HS; Hogancamp WE; Souba WW; Bland KI
Curr Surg; 1988; 45(4):312-4. PubMed ID: 3246160
[No Abstract] [Full Text] [Related]
38. Effects of ionizing irradiation on the estradiol and progesterone receptors in rat mammary tumors.
Janssens JP; Wittevrongel C; Van Dam J; Goddeeris P; Lauwerijns JM; De Loecker W
Cancer Res; 1981 Feb; 41(2):703-7. PubMed ID: 7448816
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of binding to estrogen, androgen, progestin, and glucocorticoid receptors in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and their hormonal control.
Asselin J; Melançon R; Moachon G; Bélanger A
Cancer Res; 1980 May; 40(5):1612-22. PubMed ID: 6768450
[No Abstract] [Full Text] [Related]
40. Feline mammary hypertrophy/fibroadenoma complex: clinical and hormonal aspects.
Hayden DW; Johnston SD; Kiang DT; Johnson KH; Barnes DM
Am J Vet Res; 1981 Oct; 42(10):1699-1703. PubMed ID: 7198885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
